Natural history study for nemaline myopathy patients in Belgium
Treatments studied
Part of Bones, joints & muscles, Brain & nervous system clinical trials.
This study tracks the health of people with nemaline myopathy over time to learn more about how the condition progresses. By joining, you help researchers understand the disease better, which may support future care and treatment development.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or your child must have a diagnosis of nemaline myopathy, usually confirmed by a genetic test.
- Any age and either sex can join.
- The patient (or a parent or guardian) must give written permission to be part of the study.
- You should not have other serious health conditions that could affect the study results.
- You cannot be in another treatment trial for nemaline myopathy at the same time.
- If you are pregnant, some parts of the study may need to be postponed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows patients with congenital myopathies to understand how their muscles get tired over time. It may help develop better treatments.
This study creates a network to gather information about people with nemaline myopathy, a genetic muscle disorder. It aims to improve understanding and support for future research and care.
This study follows people with nemaline myopathy over time to better understand how the disease progresses. It helps researchers learn more about the condition and plan future treatments.
This study uses motion analysis to understand walking and arm function in adults with certain neurological or metabolic diseases. The goal is to find patterns that help doctors better manage these conditions.
This study follows children with LAMA2-related muscular dystrophy to learn how the condition changes over time. It does not test a new treatment, but helps researchers understand the disease better.
This study follows people with LAMA2-related muscular dystrophy over time to better understand the condition. It may help with future treatments by learning more about how the disease progresses.
Hear when a new Nemaline Myopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.